Gender | Age group, yr | Patients, n | DMT1 | DMT2 | GDM | IGT | Overweight | Obese | HPN | CHD |
---|---|---|---|---|---|---|---|---|---|---|
Men | 7 to 17 | 1,376 | 0.4 (0.1 to 0.8) | 4.6 (3.5 to 5.7) | Â | 5.6 (4.4 to 6.8) | 15.2 (13.3 to 17.1) | 12.0 (10.3 to 13.7) | 1.3 (0.71 to 1.9) | 0 |
 | 18 to 45 | 1,581 | 1.83 (1.2 to 2.5) | 15.8 (14.0 to 17.5) |  | 10.9 (9.4 to 12.4) | 29.4 (27.2 to 31.7) | 28.8 (26.6 to 31.1) | 16.8 (14.9 to 18.6) | 2.3 (1.6 to 3.1) |
 | 46 to 60 | 823 | 2.94 (1.8 to 4.1) | 49.9 (46.5 to 53.4) |  | 9.9 (7.8 to 11.9) | 39.0 (35.7 to 42.4) | 37.6 (34.3 to 40.9) | 41.6 (38.2 to 45.0) | 11.2 (9.1 to 13.4) |
 | 61 to 80 | 586 | 4.1 (2.5 to 5.7) | 61.0 (57.0 to 64.9) |  | 7.9 (5.7 to 10.1) | 37.6 (33.7 to 41.6) | 27.8 (24.2 to 31.4) | 57.2 (53.2 to 61.2) | 16.2 (13.1 to 19.2) |
Women | 7 to 17 | 1,143 | 0.4 (0.1 to 1.0) | 4.3 (3.1 to 5.5) | Â | 5.5 (4.2 to 6.9) | 18.5 (16.3 to 20.8) | 12.9 (10.9 to 14.8) | 1.4 (0.72 to 2.1) | 0 |
 | 18 to 45 | 2,373 | 0.9 (0.6 to 1.3) | 9.6 (8.4 to 10.8) | 1.39 (1.03 to 1.75) | 8.6 (7.5 to 9.8) | 26.9 (25.1 to 28.7) | 36.4 (34.5 to 38.4) | 12.2 (10.8 to 13.5) | 1.03 (0.62 to 1.4) |
 | 46 to 60 | 935 | 3.23 (2.1 to 4.4) | 44.1 (40.8 to 47.3) | 1.5 (0.92 to 2.04) | 13.9 (11.6 to 16.1) | 25.4 (22.6 to 28.2) | 61.9 (58.7 to 64.9) | 39.9 (36.7 to 43.0) | 9.7 (7.8 to 11.6) |
 | 61 to 80 | 332 | 6.08 (3.5 to 8.6) | 53.2 (47.8 to 58.6) |  | 12.4 (8.9 to 16.0) | 30.7 (25.7 to 35.7) | 46.5 (41.1 to 51.9) | 61.1 (55.8 to 66.4) | 12.1 (8.6 to 15.7) |